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 2 
SUMMARY 
Over the past few decades, a variety of different reagents for stem cell maintenance 
and differentiation have been commercialized. These reagents share a common goal 
in facilitating the manufacture of products suitable for cell therapy whilst reducing the 
amount of non-defined components. Lessons from developmental biology have 
identified signalling molecules that can guide the differentiation process in vitro, but 
less attention has been paid to the extra-cellular matrix used. With the introduction of 
more biologically relevant and defined matrices, that better mimic specific cell niches, 
researchers now have powerful resources to fine-tune their in vitro differentiation 
systems, that may allow the manufacture of therapeutically relevant cell types. In this 
review article, we revisit the basics of the extracellular matrix, and explore the 
important role of the cell-matrix interaction. We focus on laminin proteins since they 
help to maintain pluripotency and drive cell fate specification.    
 
 
 
 
 
Keywords: 
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 3 
INTRODUCTION  
 
Following the derivation of human embryonic stem cells (hESC) in 1998
1
, and with 
the development of human induced pluripotent stem cells (hiPSC) in 2007
2, 3
, stem 
cell research is rapidly progressing from preclinical studies to the clinical arena with 
first in-human trials already begun. Continued growth in the cell therapy industry and 
the commercialization of cell therapies has led to an increased awareness for the need 
of specialized and defined materials.  
Current practices for the maintenance and expansion of undifferentiated 
human pluripotent stem cells (hPSCs) typically depend on the support of undefined 
culture systems, such as feeder cells (often mouse embryonic fibroblasts) or 
undefined basement membrane (BM) extracts such as Matrigel
™
 and Geltrex
®
 
containing laminin-111, entactin, collagen, heparin sulfate proteoglycans and growth 
factors purified from Engelbreth-Holm-Swarm mouse sarcoma. Besides the risk of 
transmitting pathogens and the introduction of tumor-derived growth factors, culture 
conditions that depend on these undefined support systems limit experimental 
reproducibility and the ability to interpret mechanistic studies due to lot-to-lot 
variations. Ultimately, they hinder the transition of hPSC-derived products into a 
clinical setting.  
Over the past decade, several feeder-free, extracellular matrix (ECM) protein 
culture matrices have appeared on the market that are defined and xeno-free
4-6
. 
However, not all ECM proteins are suitable for hPSC culture since they cannot 
maintain an undifferentiated
7
 or allow clonal survival of hPSCs without the use of 
apoptosis inhibitors or undefined additives
8
. Moreover, hPSCs were often passaged as 
clumps on these substrates, which significantly induced the risk of spontaneous 
differentiation
8
. High production costs, labour intensive cell passaging and the limited 
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 4 
scale-up potential associated with many of these ECM substrates have driven 
researchers to seek alternative substrates in the synthetic polymer arena. For example, 
Synthemax
™
, an acrylate surface with deposits of various peptide-polymer conjugates, 
has been developed for the adhesion and expansion of hESC
9
. Synthetic scaffolds 
composed of poly(desaminotyrosyl tyrosine ethyl ester carbonate)
10
, a tyrosine 
derived polycarbonate polymer
11
, have also been utilised to study the effects of 
geometry on hESC survival and self-renewal. Carlson et al. have shown that poly-D-
lysine pre-treated scaffolds support hESC survival and colony formation. However, 
the authors also illustrated the importance of cell-ECM interactions for cell 
functionality and concluded that the endogenous cell production of laminin was an 
essential factor for adhesion and survival of the hESCs
10
.  
A lack of biologically relevant signals from the matrix increases the risk for 
mixed cell populations and genetic and phenotypic drift in vitro. Compared to many 
other feeder-free matrices on the market, full-length laminin-521 better mimics the 
natural environment for hPSCs in culture
7, 8, 19
. Due to their biologically relevant 
interactions with cells, laminin-based substrates have significantly advanced the stem 
cell research field and are therefore the focus of this article. Over the last decade, 
laminins have become a preferred cell culture substrate both within basic research as 
well as for researches and companies with a therapeutic focus
45
.  
 
THE EXTRACELLULAR MATRIX AND THE IMPORTANCE OF 
BIOLOGICAL RELEVANCE FOR CELL CULTURE  
Most organized and stationary cells of the body grow on specialized, sheet-like ECM 
structures called basement membranes (BM). Different cells and tissues require a 
specific ECM composition for survival and proper function
12
, and many cells, such as 
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 5 
fibroblasts
13
, endothelial cells
14
 and cardiomyocytes
15
, themselves produce and 
deposit ECM proteins. The BM contains specific, highly conserved proteins, and 
consists mostly of laminin, type IV collagen, agrin, perlecan, fibronectin and 
nidogen
12, 16
 (Figure 1a).  
Over the past 40 years, several adhesion molecules (fibronectin, vitronectin, 
laminin-111, or a placenta-derived mixture of laminins) have been discovered and 
used to improve cell cultures
17, 18
. The concept of adhesive matrix molecules has 
gradually improved: adhesion is not only for anchoring cells in place but is also 
crucial for cell survival and phenotype maintenance. Cells which lack their relevant 
ECM cues undergo anoikis, controlled suicide, which is a natural mechanism that 
allows for the correct organization of tissues and for the selection of specific cell 
types. Laminin and type IV collagen form networks that have a structural role, 
influence cell migration and regulate the differentiation processes of associated cells. 
Nidogens are sulfated glycoproteins that link the BM proteins together, and the 
glycosaminoglycan-containing perlecan and agrin bind growth factors and contribute 
to the matrix volume
19
. Laminins are the most abundant component of the BM. In 
addition to their structural functions, laminins play an essential role in the structural 
organization of the BM and the regulation of cell behaviour
20
.  
Laminins are multidomain, heterotrimeric glycoproteins, composed of three 
different subunits; an α-chain, β-chain and γ-chain, combined and expressed in at least 
16 different isoforms in the human body
16, 19
. The physical, topological, and 
biochemical expression of the different laminin isoforms in the BM is heterogeneous 
and laminin expression changes during development. Laminin-111 is widely 
expressed during embryogenesis, but its tissue distribution after birth is restricted to 
only a few tissues, such as the brain and kidney
21
. After birth, the α5-laminins are 
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 6 
most common
22
. Without the right combination of laminin isoforms cells and tissues 
becomes dysfunctional. While epithelial cells need laminin-332 together with laminin 
-511/521 for proper function, muscle and nerve cells require laminin -211, -221 and 
laminin -511/521, and endothelial cells prefer a combination of laminin -411/421 and 
laminin -511/521
19
.  
The molecular structure of laminins is cross-shaped with the N-terminal ends 
forming three short arms, containing globular laminin N-terminal domains and a 
globular laminin IV domain
23, 24
. Each of these domains are separated by rod-like, 
epidermal-growth-factor-like domains, harbouring nidogen binding sites
25
. Nidogen 
and perlecan in turn, allow the laminin network to be connected to collagen IV. The 
globular N-terminal domains also bind to syndecans which regulate cell adhesion and 
motility
26, 27
 (Figure 1b). Cells bind to laminins via cell-surface receptors, such as 
integrins, which regulate vital cellular responses, such as proliferation and 
differentiation, migration, phenotype stability, and resistance to apoptosis
19, 28, 29
. The 
α5-laminins (especially laminin -511 and laminin -521) exhibit the broadest degree of 
integrin binding interactions
22
. There are many binding sites on the full-length 
laminin molecule which can interact with cell membrane receptors, however, the 
molecular mechanism underlying the laminin-mediated signalling to integrins and 
other cell surface receptors is still not fully elucidated. Studies indicate that the LG 
domains in C-terminal region of laminins are highly involved in laminin recognition 
by integrins
30, 31
. Integrins, α-dystroglycan, perlecan and sulphated glycolipids also 
interact with some of the globular N-terminal laminin domains
16, 32
. Fractionated 
laminin molecules isolated from tissue and truncated laminin molecule derivates lack 
most of the laminin domains that are required for the formation of a proper 
extracellular network. Moreover, full-length recombinant laminins with all their 
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 7 
native biological activities intact are essential for biomimetic in vitro function
33 
and 
for the stimulation of authentic cellular signal transductions. Emphasizing biology and 
mimicking the natural matrix proteins is one of the most important aspects to create a 
biologically relevant milieu for the cells, resulting in phenotypically stable cell 
cultures and reproducible protocols.  
 
BIOLOGICALLY RELEVANT CELL CULTURE MATRICES ENABLE 
CLINICAL TRANSLATION OF RESEARCH PROTOCOLS 
Advancing a PSC-derived cell therapy from pre-clinical studies to a Phase 1 clinical 
trial requires a demonstration of a well-controlled production process and a safe and 
efficacious product to the regulatory agencies. The development of a differentiation 
protocol that generates the target cell type at a sufficient quantity and purity, with 
phenotypic maturity and appropriate cellular functions is arguably challenging. Due to 
their validated functionality and biological properties, human recombinant laminins in 
conjunction with streamlined differentiation protocols, offer exciting prospects for 
regenerative medicine. This has been highlighted in a number of high-impact 
scientific articles in the past two years and a few examples are described below: 
 
Pluripotent stem cell derivation, maintenance and safety 
In the developing embryo, laminins containing the α1- and α5-chain are the first ECM 
proteins to be expressed. They are essential for early embryogenesis and initiation of 
morphogenesis
20
.  α5-chain laminins (i.e. laminin-521 and laminin-511) are produced 
by and surround the cells in the inner cell mass of the blastocyst which gives rise to 
all embryonic tissues
12, 19, 34
 (Figure 1c). α5 laminin is also produced endogenously by 
pluripotent hPSCs cultured in vitro and is a critical autocrine and paracrine factor that 
regulates hPSC survival and self-renewal. Knockdown and disruption of the LAMA5 
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 8 
gene dramatically reduces hPSC self-renewal and increases apoptosis
7
. LN-521 thus 
constitutes the relevant niche for pluripotent stem cells when cultured in vitro. 
Laminin-111 is mostly expressed in the Reichert’s membrane, which supports the 
outer extra-embryonic layer of trophoblasts and is widely expressed during 
embryogenesis
12, 35
 (Figure 1d). Hence, using cell culture substrates that contain 
laminin-111 (e.g. Matrigel or Cultrex) is suboptimal for reliable survival and 
expansion of hESCs and hiPSCs 
8, 19, 28
. Human ESCs dissociated into single-cell 
suspension and plated on Matrigel, or different human recombinant laminin (LN) 
substrates, LN-111, LN-121, LN-511 and LN-521, in the presence of apoptosis 
inhibitor (ROCK inhibitor, Y-27632), survive on all surfaces. However, in the 
absence of ROCK inhibitor, hESCs do not survive well on Matrigel, LN-111 or LN-
121, whereas they readily adhere and spread on LN-511 and LN-521
8
. By culturing 
cells on the laminin isoforms that they normally adhere to in vivo in vitro, the 
biologically relevant niche is better recapitulated by the medium and the matrix. 
In 2014, Rodin et al. first described an efficient xeno-free and chemically 
defined protocol for monolayer culturing of hPSC on LN-521
36
 (Figure 2a). Via the 
interaction to specific hPSC cellular receptors, LN-521 triggers authentic cell 
signalling pathways, which promotes high survival (Figure 2b) and robust long-term 
expansion of single-cell cultured hESC and hiPSC (Figure 2c), even without the 
addition of ROCK inhibitor or any other inhibitors of anoikis. LN-521 binds to β1 
integrin receptors, primarily α6β1, which plays a pivotal role in the stem cell-matrix 
interaction. Human PSCs predominantly express the α6β1 integrin, which interacts 
strongly with LN-521 globular domains inducing the PI3K/Akt pathway
8, 37, 38
. The 
inactivation of focal adhesion kinase (FAK) signalling pathway via the α6β1 integrin 
is also linked the hPSC self‐renewal and expression of pluripotency
39
. The motility of 
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 9 
hPSCs on LN-521 is higher than that of the cells on other matrices, which correlates 
to the high survival of the cells
8
.  
Human PSCs in single-cell suspension plated on LN-521 quickly attach, 
migrate and form monolayer colonies which rapidly expand (Figure 2a). Human PSCs 
cultured in thick multilayer colonies often require manual, arbitrary removal of 
spontaneously differentiated parts. In contrast, hPSCs cultured on LN-521 grow as a 
homogenous monolayer, with minimal risk of spontaneous differentiation or genetic 
abnormalities
40
. The biologically relevant culture environment generates hPSC 
cultures with a more uniform gene expression between different hPSC lines
41
 and 
enhances cell maturation, polarization and functional organization in many cell 
applications
42, 43, 44
.  
The LN-521 matrix also allows efficient clonal derivation, clonal survival and 
long-term self-renewal of hESCs. Human ESC lines can even be derived from a 
single blastomere under chemically defined and xeno-free conditions
8, 45
, which 
circumvents the ethical issues associated with embryo destruction for hESC line 
derivation. The biologically relevant culture environment provided by the LN-521 
substrate allows for flexible culture protocols that support weekend-free feeding
40
, 
ultra-low seeding density (>5,000 cells/cm
2
) and high confluence culture.  
 
Stem cell derived dopamine progenitors from a high-yield GMP-adapted 
differentiation protocol 
 
Parkinson’s disease (PD) is an interesting target for cell replacement therapies due to 
its focal degeneration of midbrain dopamine (DA) neurons.  Proof-of-concept has 
been achieved in clinical trials using human foetal ventral mesencephalic (VM) 
tissue
46
. However, the low availability of such tissue limits its use, and a renewable 
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 10
source of cells is required in order to develop a therapy that is accessible to a large 
number of patients. 
A new differentiation protocol that efficiently and rapidly patterns hESCs to 
midbrain DA neurons using extrinsic patterning agents has been developed in recent 
years
47, 48
. These stem cell derived DA neurons function en par with fetal midbrain 
DA neurons
49
. Kirkeby et al. have developed a fully defined and xeno-free protocol. 
Even so, a number of steps were required to develop a Good Manufacturing Practice 
(GMP) version compliant with use in clinical trials
44, 50
. One important step was to 
switch from an initial suspension culture step to a fully attached protocol. Matrigel 
had previously been used for this purpose
32
 but is not ideal for GMP manufacturing 
and more suitable substrates, such as recombinant laminins were required for GMP 
production. 
Seven different recombinant laminin isoforms were screened for their ability 
to replace Matrigel/free floating suspension cultures and 4 of them were found to 
efficiently support adherent differentiation of VM progenitors (LN-111, LN-421, LN-
511 and LN-521). It has previously been reported that LN-511 and LN-521 efficiently 
support growth of hPSCs
8
, making them less ideal in this differentiation protocol. In 
contrast, undifferentiated hESCs detach from LN-111-coated culture dishes when 
kept in pluripotency medium but efficiently attach in neural differentiation medium 
making it an ideal substrate to move forward with.  
When implementing this in the GMP protocol, the differentiation on LN-111 
resulted in robust and reproducible differentiation of midbrain DA progenitors with 
minimal variation between batches
44, 50
. Moreover, the yield was >40 times higher 
than the original research grade differentiation protocol
44, 48
 (Figure 3a). This high 
yield means that it is possible to produce >3.8 x 10
8
 transplantable progenitor cells in 
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 11
16 days when starting from just 1 x 10
6
 undifferentiated hESCs
44
 (Figure 3b). This 
would provide more than 500 doses of cryopreserved DA neurons from one manual 
manufacturing batch at a relatively small scale. 
 
Recombinant laminins support the differentiation potential of satellite cell-
derived myoblasts during long-term culture 
Every tissue in the body originates from a stem cell during development but there are 
a number of tissues where stem cells exist to facilitate tissue regeneration in the adult. 
In skeletal muscle, that stem cell is called the satellite cell and it remains quiescent 
unless stimulated by muscle damage
51
. Upon damage, it enters a program to 
asymmetrically expand to generate a transit amplifying cell and another satellite cell
52, 
53
. The transit amplifying cell undergoes several rounds of division to create a 
population of cells called myoblasts that can fuse together to create new muscle fibers 
or fuse to existing fibers to repair membrane lesions.    
Large-scale expansion of muscle stem cells in vitro is critical for a variety of 
purposes. Large quantities of satellite cells are required for cell engineering, cell 
therapy and to support skeletal muscle drug discovery campaigns. Relatively small 
numbers of primary satellite cells must be scalable to millions, even billions of cells, 
while maintaining the ability to differentiate into mature myotubes. While multiple 
substrates have been commonly used for growth of satellite cells, long term effects of 
culturing on different substrates has not been well characterized. Matrigel is 
commonly utilized, however, it is a complex substrate exhibiting significant lot-to-lot 
variation, and variable amounts of growth factors that may skew experimental 
outcomes and mitigates reliable translation of protocols from the literature to drug 
discovery applications
54
. Additionally, Matrigel implementation varies largely from 
lab to lab making it difficult to reliably translate protocols from the literature for drug 
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discovery applications. In order to develop an optimized and defined culture platform, 
an in-depth comparison of long-term satellite cell activity between multiple defined 
extracellular matrices and Matrigel has been performed. It was shown that LN-521 
dramatically enhances the proliferation and differentiation of satellite cells and 
extends their culture potential well past previously established passaging limits
43
. 
Following eight passages in vitro, LN-521 expanded satellite cells form more mature 
myotubes containing high numbers of nuclei and better organization compared to the 
other substrates (Figure 3c). In contrast, both LN-111 and Matrigel expanded cultures 
contain smaller immature myotubes with small numbers of nuclei (Figure 3d), an 
effect observed with both human and mouse derived satellite cells. Overall, it was 
demonstrated that LN-521 provides a good substrate that enables large-scale 
expansion in a shorter time while maintaining a differentiation performance that better 
resembles freshly isolated cells
43
.  
Additional work from Penton and colleagues has demonstrated that cells 
grown on LN-521 show enhanced engraftment into skeletal muscle niches in vivo 
(unpublished). Although there have been many publications that suggest the limited 
utility of satellite cells for cell therapy, those experiments may have been flawed since 
they employed satellite cells that had already lost some of their expansion and 
differentiation potential in vitro. Interestingly, satellite cell markers including pax7 
and integrin alpha 7 were expressed at similar levels across substrates suggesting that 
LN-521 is regulating satellite cell activity through novel mechanisms (unpublished). 
Plating satellite cells on LN-521 immediately after isolation by fluorescence activated 
cell sorting (FACS) appears to fundamentally protect the cells from the loss of the 
expansion and differentiation abilities. Penton and colleagues are investigating 
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additional approaches that should permit enhanced expansion and engraftment to 
develop advanced therapeutic approaches for patients with muscular dystrophies.  
Previous studies have shown that transplanted hPSC-derived myogenic cells 
can fuse with host myofibers and improve muscle function
55
. However, it is unknown 
if hPSC-derived myotubes alone can generate 3D functional skeletal muscle since 
comparison studies suggest they are more developmentally immature than primary 
myotubes. By trying to mimic the tissue architecture both with biologically relevant 
matrix molecules and different 3D approaches, it is possible to generate functional 
biomimetic skeletal muscle tissues entirely from hPSC-derived myogenic cells
56
.  
 
Recombinant laminins drive the differentiation and self-organization of hESC-
derived hepatocytes  
There has been tremendous progress over the last 15 years in generating pure 
populations of endodermal cells, including hepatocytes, for biomedical application
57
. 
While cell-based models improve the ability to model human liver biology ‘in the 
dish’ and may be suitable for cell-based therapy, most approaches rely on undefined 
materials in the differentiation process
58
. This severely limits technology 
reproducibility and scale up, acting as a barrier to technology translation. 
In recent years, serum free and chemically defined differentiation procedures 
have been developed
59
 that have been validated by the pharmaceutical industry to be 
as good as their current gold standard
60
. While this marked progress at the time, the 
early prototype systems still relied on poorly defined ECMs, such as Matrigel, which 
resulted in batch-to-batch variation. Since these studies, a differentiation system has 
been designed using polymer library screening to identify new polyurethane 
substrates for cell culture
61, 62
.  
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More recently, differentiation has been performed using recombinant 
laminins
42
. This enabled a highly reproducible and transformative differentiation 
process, which has been semi-automated to permit large scale manufacture.  
Importantly, cells generated in this manner express proteins, HNF4a, MRP1 and 
albumin, found in hepatocyte (Figure 3e and f). An essential part of the stem cell 
scale-up is the ability to use highly defined ‘off the shelf reagents’.   
 
FROM HERE TO THE FUTURE: ENABLING CELL THERAPY  
Pluripotent stem cells, whether they are derived from human embryos or 
reprogrammed adult or foetal somatic cells, have an intrinsic capability for unlimited 
self-renewal and the ability to make all the cells in the body. They are therefore an 
ideal candidate to be used as starting material for cell therapies. Much effort has been 
put into creating methods for hPSC expansion that are defined, robust, simple and 
safe
63
. Having a defined method ensures lo  variance, high-quality, traceability and 
control over reagents, all required for manufacture of clinical grade cells. The 
robustness of the method allows consistency of results and predictability. A simple 
and controlled method reduces cost, minimizes the risk for mistakes, and will more 
likely be adapted by users. Ultimately, the most important aspect of the hPSC culture 
method is to create a safe cell source. With extended time in culture, cells may begin 
to drift genetically, resulting in chromosomal abnormalities. Although hPSCs have an 
impressive ability to maintain genomic integrity over time, chromosomal 
abnormalities often occur at higher passages and/or as a result of suboptimal culture 
conditions
40, 64, 65
.   
 
Cell therapy grade cell culture substrates  
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The stem cell therapy field is still in its infancy. Translational researchers are now 
looking more intensely at the quality and character of both the cell products and the 
culture products used for primary, stem and differentiated cells. So far, FDA and 
EMA have not demanded GMP for phase 1 studies but it is evident that the methods 
employed today will not be sustainable for commercial therapies. As a consequence, 
the conversion of optimized, scalable, and standardized culture methods into GMP-
compatible protocols will become another challenge. Each and every reagent needs to 
be high quality, traceable, controlled and preferably manufactured according to GMP. 
To address these issues a cell therapy grade (CTG) LN-521 substrate has been 
developed to enable cell therapy fast forward to an affordable price. The CTG LN-
521 substrate is stably expressed and produced by CAP

Go cell, a suspension-based 
platform already used for therapeutic proteins in human clinical trials, and is a 
validated source of protein of ethically accepted origin. A qualified GMP master cell 
bank (MCB) together with a scalable and regulatory compliant production process of 
CTG LN-521, serve as the foundation for translational research and cell manufacture.  
 
Cell culture at the appropriate scale and with automation  
Generation of hESC and hiPSC lines is laborious. To decrease the amount of work 
needed, increase success rates and minimize hazardous deviations, the process needs 
to be standardized. In addition, an automated process is desirable to avoid subjective, 
operator-dependent mistakes and to cut costs. 
Generally, upscaling is achieved by manual expansion in traditional culture 
vessels or through scalable planar flask cultures, which all involve multi-layered 
stacked-plate systems. Automation of traditional culture vessels, such as plates and 
flasks, can be achieved by pipetting (semi or whole) closed system robotics. Another 
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approach is packed-bed bioreactors which are perfusion-based 3D scaffolds. A further 
type of bioreactor supported system offering the precise control of the culture 
environment is microcarrier culture in stirred tanks, ideal systems for achieving 
required lot sizes. The surface-area-to-volume is greatly increased and thus renders 
more cells with less medium, reagents and materials
66
. 
Stem cell scale-up and subsequent differentiation would ideally be performed 
in the same, closed, automated and fully controlled bioreactor. Human recombinant 
laminin can easily be adsorbed by microcarriers (e.g. Corning® Enhanced Attachment 
Microcarriers) and LN-521 coated microcarriers have been shown to sustain 
expansion of both hESC and hiPSCs in stirred tank bioreactors, with sequential 
differentiation to cardiomyocytes
67
 (Figure 2d). 
 
Importance of biological relevance: spatial, temporal and regional impact  
The development of robust protocols that safely and accurately direct hESC and 
hiPSC into the desired cell types, mimicking the signalling that occurs during 
development is difficult to achieve in vitro. While many protocols successfully 
recapitulate the temporal developmental processes via well designed medium 
formulations, the majority of protocols ignore the role of the ECM and the spatial and 
tissue specific distribution of the ECM proteins that form the tissue architecture. 
One of the biggest and most obvious differences between cells cultured in 2D 
versus 3D is their morphology. The orientation of the integrin mediated adhesions, 
guides the orientation and thus the shape of the cells.  A 3D microenvironment 
influences the attachment, spreading, growth, and most importantly cell polarity
68, 69
. 
The limitations of 2D cultures have contributed to poor predictive power of pre-
clinical cell-based drug and toxicity screening assays. Human recombinant laminins, 
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in combination with other key ECM molecules, can be used together with various 
available 3D solutions. Hydrogels can be covalently linked with proteins and thus 
serve as a 3D context for the cells. In addition, recombinant silk proteins can be used 
as scaffolds that can easily be adsorbed with e.g. LN-521 to maintain and differentiate 
hESCs towards different lineages. In order to mirror the correct in vivo tissue 
assembly ex vivo, and to regenerate damage tissue and even repair whole body parts, 
biologically relevant and physiological matrices in a structure allowing spatial 
orientation need to be developed. 
This article has been designed to create an awareness around the necessity and 
need for defined materials to improve basic scientific research and to permit the 
translation of these advances through reliable manufacture of cell-based products at a 
large scale. Additionally, we emphasize the importance of a close collaboration 
between the users, suppliers and regulators to facilitate the commercial development 
of safe and effective cell therapies globally. 
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FIGURE LEGENDS    
Figure 1a-c. Laminins are abundant components of the BMs and have essential roles 
in structural organization. Via binding to cell-surface receptors, such as integrins, 
laminins are also key regulators of cell behaviour (a). The molecular structure of 
laminin isoforms is cross-shaped. The Greek letters indicate the specific chains. The α 
chains have five globular domains (LG1–5) at the C terminus. The short arms are 
composed of a globular laminin N-terminal domain (LN), globular laminin IV domain 
(L4), or laminin four domain (LF). Each of these domains is separated by rod-like 
regions formed by multiple laminin epidermal-growth-factor-like (LE) domains (b). 
The α5-chain laminins are key cell adhesion proteins of the natural stem cell niche. It 
is naturally expressed and secreted by cells in the inner cell mass ICM of the embryo 
whereas the α1-chain laminins are mostly expressed in the Reichert’s membrane 
which supports the outer extra-embryonic layer of trophoblasts (c). 
 
Figure 2a-d. Human PSCs grow as homogenous monolayers on LN-521, exhibiting a 
high nuclear-to-cytoplasm ratio and prominent nucleoli. Due to the biologically 
relevant support from the matrix, hESC and hiPSC can be seeded as single cells on 
LN-521 without the need to use apoptosis inhibitors (e.g. ROCKi) for survival. 
Within 1 hour after seeding, the cells have attached and are evenly distributed across 
the surface (a, day 0). The cells show high motility on LN-521, migrate and form 
small colonies and start dividing (a, day 1). The colonies merge (a, day 3) into a 
homogenous monolayer without signs of spontaneous differentiation (a, day 4). LN-
521 supports higher post-seeding survival (24 h) of single-cell dissociated hPSCs, 
compared to Matrigel (MG) and non-relevant laminin matrices (b). In addition, 
human PSCs proliferate faster on LN-521 compared to other feeder-free matrices 
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(EHS extract; Engelbreth-Holm-Swarm mouse sarcoma extract), with about 10-fold 
increase every 4 days (c). LN-521 even enables large-scale automated processes for 
robust hPSC expansion in bioreactors. The cells easily attach, spread evenly on the 
surface of the microcarriers and gives a 20-fold expansion within 4 days (d).  
 
Figure 3a-f. Differentiation of hESCs on LN-111 towards DA cells results in more 
than 40-fold increase of transplantable DA progenitors at day 16 (a) and the human 
progenitors innervate the striatum, become tyrosine hydroxylase (TH+) neurons and 
contribute to complete behavioural recovery after transplantation into animals 
modelling PD (b; scale bar represents 1.5mm). LN-521 improves muscle cell 
proliferation and differentiation, giving larger myotubes, higher amounts of nuclei per 
myotube (express myosin heavy chain, MHC) and more consistent differentiation in 
long-term cultures (c; MHC in green) compared to cells on Matrigel (d; DAPI in blue). 
Human ESCs differentiated on LN-521 and LN-111 demonstrate efficient hepatocyte 
maturation with significant improvements in cell function
42
. The hepatocyte-like cells 
are highly organized on LN-521, express transporter protein MRP1 (e; green) and 
HNF4a (red), and a majority of the cells are albumin+ (f; green) Cell nuclei are 
visualized with DAPI (blue).  
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Figure 1a-c. Laminins are abundant components of the BMs and have essential roles in structural 
organization. Via binding to cell-surface receptors, such as integrins, laminins are also key regulators of cell 
behaviour (a). The molecular structure of laminin isoforms is cross-shaped. The Greek letters indicate the 
specific chains. The α chains have five globular domains (LG1–5) at the C terminus. The short arms are 
composed of a globular laminin N-terminal domain (LN), globular laminin IV domain (L4), or laminin four 
domain (LF). Each of these domains is separated by rod-like regions formed by multiple laminin epidermal-
growth-factor-like (LE) domains (b). The α5-chain laminins are key cell adhesion proteins of the natural 
stem cell niche. It is naturally expressed and secreted by cells in the inner cell mass ICM of the embryo 
whereas the α1-chain laminins are mostly expressed in the Reichert’s membrane which supports the outer 
extra-embryonic layer of trophoblasts (c).  
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Figure 2a-d. Human PSCs grow as homogenous monolayers on LN-521, exhibiting a high nuclear-to-
cytoplasm ratio and prominent nucleoli. Due to the biologically relevant support from the matrix, hESC and 
hiPSC can be seeded as single cells on LN-521 without the need to use apoptosis inhibitors (e.g. ROCKi) for 
survival. Within 1 hour after seeding, the cells have attached and are evenly distributed across the surface 
(a, day 0). The cells show high motility on LN-521, migrate and form small colonies and start dividing (a, 
day 1). The colonies merge (a, day 3) into a homogenous monolayer without signs of spontaneous 
differentiation (a, day 4). LN-521 supports higher post-seeding survival (24 h) of single-cell dissociated 
hPSCs, compared to Matrigel (MG) and non-relevant laminin matrices (b). In addition, human PSCs 
proliferate faster on LN-521 compared to other feeder-free matrices (EHS extract; Engelbreth-Holm-Swarm 
mouse sarcoma extract), with about 10-fold increase every 4 days (c). LN-521 even enables large-scale 
automated processes for robust hPSC expansion in bioreactors. The cells easily attach, spread evenly on the 
surface of the microcarriers and gives a 20-fold expansion within 4 days (d).  
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Figure 3a-f. Differentiation of hESCs on LN-111 towards DA cells results in more than 40-fold increase of 
transplantable DA progenitors at day 16 (a) and the human progenitors innervate the striatum, become 
tyrosine hydroxylase (TH+) neurons and contribute to complete behavioural recovery after transplantation 
into animals modelling PD (b; scale bar represents 1.5mm). LN-521 improves muscle cell proliferation and 
differentiation, giving larger myotubes, higher amounts of nuclei per myotube (express myosin heavy chain, 
MHC) and more consistent differentiation in long-term cultures (c; MHC in green) compared to cells on 
Matrigel (d; DAPI in blue). Human ESCs differentiated on LN-521 and LN-111 demonstrate efficient 
hepatocyte maturation with significant improvements in cell function42. The hepatocyte-like cells are highly 
organized on LN-521, express transporter protein MRP1 (e; green) and HNF4a (red), and a majority of the 
cells are albumin+ (f; green) Cell nuclei are visualized with DAPI (blue).  
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